To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .

PHASE4CompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

November 30, 2005

Conditions
ImpotenceHypertension
Interventions
DRUG

Sildenafil Citrate

Trial Locations (16)

31238

Pfizer Investigational Site, Chihuahua City

34300

Pfizer Investigational Site, Durango

44290

Pfizer Investigational Site, Guadalajara

52140

Pfizer Investigational Site, Metepec

64000

Pfizer Investigational Site, Monterrey

64460

Pfizer Investigational Site, Monterrey

72000

Pfizer Investigational Site, Torreón

72090

Pfizer Investigational Site, Puebla City

78090

Pfizer Investigational Site, San Luis Potosí City

78240

Pfizer Investigational Site, San Luis PotosÃ-

97070

Pfizer Investigational Site, Mérida

06090

Pfizer Investigational Site, Colonia Centro

06760

Pfizer Investigational Site, DF

07760

Pfizer Investigational Site, Mexico City

C.P. 20230

Pfizer Investigational Site, Aguascalientes

C.P. 97897

Pfizer Investigational Site, Veracruz

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00150358 - To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension . | Biotech Hunter | Biotech Hunter